Skip to main content
. 2021 Apr 24;11(4):e046563. doi: 10.1136/bmjopen-2020-046563

Figure 2.

Figure 2

ICERs as a percentage of national GDP per capita, monoclonal antibody. GDP, gross domestic product; ICERs, incremental cost-effectiveness ratios.